Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Value Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.4 USD | +0.18% |
|
-5.63% | +67.16% |
07-01 | Y-mAbs Therapeutics Appoints Peter Pfreundschuh as CFO | MT |
07-01 | Y-mAbs Therapeutics, Inc. Announces the Appointment of Peter Pfreundschuh as Chief Financial Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.16% | 500M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- YMAB Stock
- News Y-mAbs Therapeutics, Inc.
- Y-mAbs Therapeutics, Inc.(NasdaqGS: YMAB) dropped from Russell 3000E Value Index